In vivo γ-aminobutyric acid increase as a biomarker of the epileptogenic zone: An unbiased metabolomics approach.

Hamelin S, Stupar V, Mazière L, Guo J, Labriji W, Liu C, Bretagnolle L, Parrot S, Barbier EL, Depaulis A, Fauvelle F

Open source

DOI
10.1111/epi.16768
Published
2021 Jan
Container
Epilepsia
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/epi.16768,
  title = {In vivo γ-aminobutyric acid increase as a biomarker of the epileptogenic zone: An unbiased metabolomics approach.},
  author = {Hamelin S and Stupar V and Mazière L and Guo J and Labriji W and Liu C and Bretagnolle L and Parrot S and Barbier EL and Depaulis A and Fauvelle F},
  year = {2021},
  journal = {Epilepsia},
  doi = {10.1111/epi.16768},
  url = {https://doi.org/10.1111/epi.16768}
}

RIS

TY  - JOUR
TI  - In vivo γ-aminobutyric acid increase as a biomarker of the epileptogenic zone: An unbiased metabolomics approach.
AU  - Hamelin S
AU  - Stupar V
AU  - Mazière L
AU  - Guo J
AU  - Labriji W
AU  - Liu C
AU  - Bretagnolle L
AU  - Parrot S
AU  - Barbier EL
AU  - Depaulis A
AU  - Fauvelle F
PY  - 2021
JO  - Epilepsia
DO  - 10.1111/epi.16768
UR  - https://doi.org/10.1111/epi.16768
ER  - 

APA

S, H., V, S., L, M., J, G., W, L., C, L., L, B., S, P., EL, B., A, D., & F, F. (2021). In vivo γ-aminobutyric acid increase as a biomarker of the epileptogenic zone: An unbiased metabolomics approach.. Epilepsia. https://doi.org/10.1111/epi.16768

Source records